Oxidative stress in the chronic phase after stroke

Redox Report

Volumn 8, Issue 3, 2003, Pages 169-176

  Alexandrova, Margarita L ^a   Bochev, Petyo G ^a   Markova, Vanya I ^a   Bechev, Blagovest ^a   Popova, Marina A ^a   Danovska, Maya P ^a   Simeonova, Virginia K ^a  

^a MEDICAL UNIVERSITY PLEVEN   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; GLUTATHIONE PEROXIDASE; LIPID PEROXIDE; OPSONIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD VESSEL INJURY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PHAGOCYTE; PRIORITY JOURNAL;

ANTIOXIDANTS; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; OPSONIN PROTEINS; OXIDATIVE STRESS; PHAGOCYTES; REACTIVE OXYGEN SPECIES; RECEPTORS, IMMUNOLOGIC; RISK FACTORS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0038785813     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100003225001548     Document Type: Article

References (42)

1. Floyd RA. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J 1990; 4: 2587-2597.
2. Ikeda Y, Long DM. The molecular basis of brain injury and brain edema: the role of oxygen free radicals. Neurosurgery 1990; 27: 1-11.
3. Kitagava K, Matsumoto M, Kimura K, Kamata T. Cerebrovascular diseases and free radicals. Jpn J Circ 1989; 25. 354-362.
4. Hallenbeck J. Cytokines, macrophages, and leukocytes in brain ischemia. Neurology 1997; 49: S5-S9.
5. Alexandrova ML, Bochev PG, Markova VI et al. Changes in phagocyte activity in patients with ischaemic stroke. Luminescence 2001; 16: 1-9.
6. Grau AJ, Berger E. Granulocyte adhesion, deformability, and superoxide formation in acute stroke. Stroke 1992; 23: 33-39.
7. Imre S, Fekete I, Farkas T. Increased proportion of decosahexanoic acid and high lipid peroxidation capacity in erythrocytes of stroke patients. Stroke 1994; 25: 2416-2420.
8. Gruener N, Gross B, Gozlan O, Barak M. Increase in superoxide dismutase after cerebral accident. Life Sci 1994; 54: 711-713.
9. Spranger M, Krempien S, Schwab S, Donnenberg S, Hacke W. Superoxide dismutase activity in serum of patients with acute cerebral ischemic injury. Correlation with clinical course and infarct size. Stroke 1997; 28: 2425-2428.
10. Yagi K. Lipid peroxides and human diseases. Chem Phys Lipids 1987; 45: 337-351.
11. van Kooten F, Giabattoni G, Koudstaal PJ et al. Increased platelet activation in the chronic phase after cerebral ischemia and intracerebral hemorrhage. Stroke 1999; 30: 546-549.
12. van Swieten J, Koudstaal P, Visser M et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604-607.
13. Brown G, Silver G, Reiff J et al. Polymorphonuclear neutrophil chemiluminescence in whole blood from blunt trauma patients with multiple injuries. J Trauma 1999; 46: 297-305.
14. Chan S, Monteiro H, Deucher G et al. Functional activity of blood polymorphonuclear leukocytes as an oxidative stress biomarker in human subjects. Free Radic Biol Med 1997; 24: 1411-1418.
15. Bochev P, Bechev B, Magrisso M. Six-sample multiplexing computerized analyzer for integral and spectral luminescence measurements. Anal Chim Acta 1992; 256: 29-32.
16. Walan A, Dahlgren C, Kihlstrom E et al. Phagocyte killing of Campylobacter jejuni in relation to oxidative activation. Pathol Microbiol Immunol Scand 1992; 100: 424-430.
17. Bechev B, Magrisso M, Bochev P et al. Dependence of whole blood luminol chemiluminescence on PMNL and RBC count. J Biochem Biophys Methods 1993; 27: 301-309.
18. Maral J, Puget K, Michoelsn A. Comparative study of superoxide dismutase, catalase and glutathione peroxidase levels in erythrocytes of different animals. Biochem Biophys Res Commun 1977; 77: 1525-1535.
19. Sigma Chemie Catalog, 1996; 235.
20. Pereslegina I. Salivary antioxidant enzymes activity in normal children. Lab Delo 1989; 11: 20-23.
21. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77.
22. Asakawa T, Matsushita S. Thiobarbituric acid test for detecting lipid peroxides. Lipids 1980; 14: 401-406.
23. Kochanek PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992; 23: 1367-1379.
24. Zweier JL, Kuppusamy P, Lutty GA. Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci USA 1988; 85: 4066-4070.
25. Kochanek PM, Nemoto EM, Evans RW, Schoettle RJ. Polymorphonuclear leukocytes, platelets, and lipid mediators in the pathogenesis of ischemic and traumatic central nervous system injury. New Trends Lipid Mediators Res 1990; 4: 220-240.
26. Elneihoum AM, Falke P, Axelsson L, Lundberg E, Lindgarde F, Ohlsson K. Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke 1996; 27: 1734-1738.
27. Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 1988; 85: 9748-9752.
28. Key Ns, Platt JL, Vercellotti M. Vascular endothelial cell proteoglycans are susceptible to cleavage by neutrophils. Arterioscler Thromb 1992; 12: 836-842.
29. Wieland E, Brandes A, Armstrong VW, Oelleich M. Oxidative modification of low density lipoproteins by human polymorphonuclear leukocytes. Eur J Clin Chem Clin Biochem 1993; 31: 725-731.
30. Yagi K. Assay for serum lipid peroxide level and its clinical significance. In: Yagi K. (ed) Lipid Peroxides in Biology and Medicine. Orlando, FL: Academic Press, 1982; 223-243.
31. Goldstein LB, Adams R, Becker K et al. AHA Scientific Statement. Primary prevention of ischemic stroke. A statement for healthcare professionals from the stroke council of the American Heart Association. Circulation 2001; 103: 163.
32. Fassbender K, Mossner R, Motsch L, Kischka U, Grau A, Hennerici M. Circulating selectin- and immunoglobulin-type adhesion molecules in acute ischemic stroke. Stroke 1995; 26: 1361-1364.
33. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-126.
34. Langlois M, Duprez D, Delanghe J, Buyzere M, Clement DL. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 2001; 103: 1863.
35. Kurl S, Tuomainen TP, Laukkanen JA et al. Plasma vitamin C modifies the association between hypertension and risk of stroke. Stroke 2002; 33: 1568.
36. Grotta JC, Alexandrov AV. Is preventing microemboli enough? Circulation 2001; 103: 2321.
37. D'Agostino RB, Wolf PA, Belanger AJ et al. Stroke risk profile: adjustment for antihypertensive medication: the Framingham Study. Stroke 1994; 25: 40-43.
38. Lilius EM, Marnila P. Photon emission of phagocytes in relation to stress and disease. Experientia 1992; 48: 1082-1091.
39. Kontos H. Oxygen radicals in cerebral vascular-injury. Circ Res 1985; 57: 508-516.
40. Benson RT, Sacco RL. Stroke prevention: hypertension, diabetes, tobacco, and lipids. Neurol Clin 2000; 18: 309-319.
41. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-3264.
42. Gillum RF, Sempos CT. The end of the long-term decline in stroke mortality in the United States? Stroke 1997; 28: 1527-1529.